ArticleNPJ systems biology and applications2026
Interpreting MALDI imaging data for rare types of ampullary cancer using machine learning.
Article in NPJ systems biology and applications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rare tumor diseases are difficult to diagnose and there is a lack of routine diagnostic procedures. Approaches must be found that allow comprehensive identification and evaluation of prognostic relevant target proteins or transcripts. Analyzing rare ampullary cancer, respectively, to their prognosis and predictive factors by machine learning (ML) based matrix-assisted laser desorption/ionization (MALDI) time-of-flight (TOF) imaging is a first step towards providing new solutions for diagnostics of those cancer samples. In this study, we investigated a cohort of ampullary adenocarcinomas, including intestinal, pancreatic and cases of unknown subtypes, to identify differences in the proteome. Human formalin-fixed paraffin-embedded (FFPE) tissues were pathologically assessed, immunohistological stained, MALDI Imaging detected, and ML-related analyzed. We enable MALDI imaging as a diagnostic complement for immunohistochemical analysis and provide a MALDI Imaging neural network for broad application in tumor diagnostics. Moreover, using tools from ML model explainability, we determined a small subset of influential m/z-values from the trained models. The transformation of locally established ML networks dependent on one proteomic application source to other similar application sources (without peak picking or other pre-processing) is the basis for future rare cancer patient data collection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.